NovaBay Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 4.89M shares, a 25.2% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.89M -1.64M -25.2% Nov 5, 2024 10-Q 2024-11-07
Q2 2024 4.89M +671K +15.9% Aug 9, 2024 10-Q 2024-08-13
Q1 2024 30.1M +28.1M +1379% Mar 22, 2024 10-K 2024-03-26
Q3 2023 6.53M -58.5M -90% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 4.21M -49.3M -92.1% Aug 7, 2023 10-Q 2023-08-10
Q1 2023 2.04M -49.4M -96% Mar 27, 2023 10-K 2023-03-31
Q3 2022 65M +20M +44.6% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 53.5M +8.57M +19.1% Aug 9, 2022 10-Q 2022-08-11
Q1 2022 51.4M +9.64M +23.1% Mar 24, 2022 10-K 2022-03-29
Q3 2021 44.9M +3.16M +7.57% Nov 10, 2021 10-Q 2021-11-12
Q2 2021 44.9M +3.2M +7.68% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 41.8M +13.8M +49.2% Mar 23, 2021 10-K 2021-03-25
Q3 2020 41.8M +13.9M +49.7% Nov 10, 2020 10-Q 2020-11-12
Q2 2020 41.7M +20.7M +98.7% Aug 4, 2020 10-Q 2020-08-06
Q1 2020 28M +10.9M +63.9% Mar 24, 2020 10-K 2020-03-26
Q3 2019 27.9M +10.8M +63.3% Nov 5, 2019 10-Q 2019-11-07
Q2 2019 21M +3.91M +22.9% Aug 6, 2019 10-Q 2019-08-07
Q1 2019 17.1M 0 0% Mar 24, 2019 10-K 2019-03-29
Q3 2018 17.1M +1.72M +11.2% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 17.1M +1.78M +11.6% Aug 3, 2018 10-Q 2018-08-07
Q1 2018 17.1M +1.8M +11.8% Mar 13, 2018 10-K 2018-03-21
Q3 2017 15.4M +233K +1.54% Nov 9, 2017 10-Q 2017-11-14
Q2 2017 15.3M +4.06M +36.1% Aug 9, 2017 10-Q 2017-08-10
Q1 2017 15.3M +10.3M +206% Mar 22, 2017 10-K 2017-03-23
Q3 2016 15.1M -72M -82.6% Nov 9, 2016 10-Q 2016-11-10
Q2 2016 11.3M -62.5M -84.7% Aug 9, 2016 10-Q 2016-08-11
Q1 2016 5M -56.1M -91.8% Feb 29, 2016 10-K 2016-03-04
Q3 2015 87.1M +35.5M +68.7% Nov 2, 2015 10-Q 2015-11-16
Q2 2015 73.8M +23M +45.2% Aug 3, 2015 10-Q 2015-08-13
Q1 2015 61.1M +10.4M +20.4% Mar 23, 2015 10-K 2015-03-26
Q3 2014 51.6M +12.2M +31% Nov 5, 2014 10-Q 2014-11-12
Q2 2014 50.8M +13.4M +35.7% Jul 28, 2014 10-Q 2014-07-31
Q1 2014 50.8M +13.8M +37.2% Apr 28, 2014 10-Q 2014-05-01
Q3 2013 39.4M +9.56M +32% Nov 11, 2013 10-Q 2013-11-14
Q2 2013 37.4M +8.46M +29.2% Jul 30, 2013 10-Q 2013-08-01
Q1 2013 37M +8.05M +27.8% Mar 11, 2013 10-K 2013-03-14
Q3 2012 29.8M +1.52M +5.38% Oct 29, 2012 10-Q 2012-11-01
Q2 2012 29M +24.9M +605% Aug 6, 2012 10-Q 2012-08-09
Q1 2012 28.9M Apr 30, 2012 10-Q 2012-05-03
Q3 2011 28.3M Nov 1, 2011 10-Q 2011-11-07
Q2 2011 4.11M Jun 30, 2011 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.